Dramatic response of aneurysmal bone cyst to denosumab: Case report and literature review |
| |
| Authors: | Pedram Fadavi,Amir Mohammad Arefpour,Ramyar Hariri,Maryam Vasheghani,Maryam Garousi,Farzad Taghizadeh‐ Hesary |
| |
| Affiliation: | 1. Radiation Oncology Department, Iran University of Medical Science, Tehran Iran ; 2. Radiation Oncology Department, Shahid Beheshti University of Medical Science, Tehran Iran |
| |
| Abstract: | Denosumab, a monoclonal antibody that specifically targets cytokine receptor activator of nuclear factor‐kappa B ligand (RANKL), is a potentially viable option in resistant aneurysmal bone cysts. |
| |
| Keywords: | aneurysmal bone cyst denosumab management RANK ligand resistant |
|
|
